Stock Events

Stock Events

Lineage Cell Therapeutics (LCTX) Q3 2024 Earnings

8AugConfirmed

Q3 2023

Q4 2023

Q2 2024

Q3 2024

-0.05

-0.04

-0.03

-0.03

Details

Expected EPS

-0.045

Actual EPS

-0.03

Surprise EPS

0.02

Surprise Percent

+33.33%

Description

Lineage Cell Therapeutics (LCTX) has reported earnings of -0.03 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.